Azenta PE Ratio 2010-2024 | AZTA
Current and historical p/e ratio for Azenta (AZTA) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Azenta PE ratio as of May 20, 2024 is 156.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Azenta PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-20 | 51.48 | 0.00 | |
2024-03-31 | 60.28 | $-2.71 | 0.00 |
2023-12-31 | 65.14 | $-0.31 | 0.00 |
2023-09-30 | 50.19 | $-0.18 | 0.00 |
2023-06-30 | 46.68 | $-0.52 | 0.00 |
2023-03-31 | 44.62 | $-0.63 | 0.00 |
2022-12-31 | 58.22 | $27.59 | 2.11 |
2022-09-30 | 42.86 | $28.32 | 1.51 |
2022-06-30 | 72.10 | $28.89 | 2.50 |
2022-03-31 | 82.88 | $29.55 | 2.80 |
2021-12-31 | 103.11 | $1.72 | 59.95 |
2021-09-30 | 102.26 | $1.49 | 68.63 |
2021-06-30 | 95.08 | $1.59 | 59.80 |
2021-03-31 | 81.40 | $1.25 | 65.12 |
2020-12-31 | 67.55 | $1.05 | 64.33 |
2020-09-30 | 45.99 | $0.88 | 52.26 |
2020-06-30 | 43.89 | $6.18 | 7.10 |
2020-03-31 | 30.19 | $6.09 | 4.96 |
2019-12-31 | 41.42 | $6.02 | 6.88 |
2019-09-30 | 36.46 | $6.04 | 6.04 |
2019-06-30 | 38.05 | $0.50 | 76.09 |
2019-03-31 | 28.73 | $0.72 | 39.90 |
2018-12-31 | 25.56 | $1.62 | 15.78 |
2018-09-30 | 34.08 | $1.65 | 20.65 |
2018-06-30 | 31.65 | $1.75 | 18.08 |
2018-03-31 | 26.19 | $1.68 | 15.59 |
2017-12-31 | 22.98 | $0.93 | 24.71 |
2017-09-30 | 29.14 | $0.90 | 32.37 |
2017-06-30 | 20.74 | $0.80 | 25.92 |
2017-03-31 | 21.34 | $0.67 | 31.85 |
2016-12-31 | 16.19 | $-0.75 | 0.00 |
2016-09-30 | 12.83 | $-1.02 | 0.00 |
2016-06-30 | 10.49 | $-1.07 | 0.00 |
2016-03-31 | 9.64 | $-1.08 | 0.00 |
2015-12-31 | 9.80 | $0.18 | 54.44 |
2015-09-30 | 10.65 | $0.21 | 50.73 |
2015-06-30 | 10.32 | $0.11 | 93.78 |
2015-03-31 | 10.39 | $0.36 | 28.86 |
2014-12-31 | 11.29 | $0.37 | 30.53 |
2014-09-30 | 9.23 | $0.46 | 20.07 |
2014-06-30 | 9.38 | $0.55 | 17.05 |
2014-03-31 | 9.44 | $0.21 | 44.94 |
2013-12-31 | 8.99 | $0.15 | 59.92 |
2013-09-30 | 7.92 | $-0.04 | 0.00 |
2013-06-30 | 8.20 | $1.64 | 5.00 |
2013-03-31 | 8.51 | $1.74 | 4.89 |
2012-12-31 | 6.68 | $1.89 | 3.53 |
2012-09-30 | 6.60 | $2.08 | 3.17 |
2012-06-30 | 7.67 | $0.50 | 15.35 |
2012-03-31 | 9.94 | $1.40 | 7.10 |
2011-12-31 | 8.22 | $1.67 | 4.92 |
2011-09-30 | 6.47 | $1.98 | 3.27 |
2011-06-30 | 8.55 | $2.17 | 3.94 |
2011-03-31 | 10.81 | $0.92 | 11.75 |
2010-12-31 | 7.14 | $0.10 | 71.41 |
2010-09-30 | 5.28 | $-2.69 | 0.00 |
2009-09-30 | 6.09 | $-2.74 | 0.00 |
2009-06-30 | 3.53 | $-2.25 | 0.00 |
2009-03-31 | 3.63 | $-1.88 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.776B | $0.665B |
Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.316B | 20.49 |
Inspire Medical Systems (INSP) | United States | $4.614B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.995B | 0.00 |
Axonics (AXNX) | United States | $3.446B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $2.976B | 0.00 |
10x Genomics (TXG) | United States | $2.959B | 0.00 |
IRhythm Technologies (IRTC) | United States | $2.881B | 0.00 |
Enovis (ENOV) | United States | $2.806B | 20.79 |
Privia Health (PRVA) | United States | $1.920B | 107.27 |
Schrodinger (SDGR) | United States | $1.643B | 0.00 |
Omnicell (OMCL) | United States | $1.411B | 48.78 |
Phreesia (PHR) | United States | $1.359B | 0.00 |
Standard BioTools (LAB) | United States | $0.749B | 0.00 |
Definitive Healthcare (DH) | United States | $0.669B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
Talkspace (TALK) | United States | $0.475B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.445B | 0.00 |
Health Catalyst (HCAT) | United States | $0.408B | 0.00 |
Pulmonx (LUNG) | United States | $0.346B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.297B | 0.00 |
Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
Outset Medical (OM) | United States | $0.187B | 0.00 |
P3 Health Partners (PIII) | United States | $0.173B | 0.00 |
American Well (AMWL) | United States | $0.151B | 0.00 |
TruBridge (TBRG) | United States | $0.135B | 7.26 |
111 (YI) | China | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.099B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
HeartBeam (BEAT) | United States | $0.067B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.061B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
Augmedix (AUGX) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.056B | 0.00 |
CareCloud (CCLD) | United States | $0.045B | 0.00 |
Movano (MOVE) | United States | $0.043B | 0.00 |
Akili (AKLI) | United States | $0.033B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
Cue Health (HLTH) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |